REFERENCES
- Ronday HK, Smith HH, Van Muijen GNP et al.: Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis. Br J Rheumatol 35: 416–423, 1996.
- Gabazza EC, Taguchi O, Yamakami T et al.: Correlation between clotting and collagen metabolism markers in rheumatoid arthritis. Thromb Haemostas 71: 199–202, 1994.
- Lau CS, McLaren M, Hanslip J et al: Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis. Ann Rheum Dis 52: 643–649, 1993.
- Motohashi Y, Nakazawa T, Kojima A: Analysis of blood coagulation and fibrinolysis in rheumatoid arthritis using the urokinase activated thromboelastography. Ryumachi 32: 123–130, 1992 (in Japanese).
- Weinberg JB, Pippen AMM, Greenberg CS: Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum 34: 996–1005, 199).
- Kawakami M, Kawagoe M, Harigai M et ah: Elevated plasma levels of c*2-plasmin inhibitor-plasmin complex in patients with rheumatic diseases. Arthritis Rheum 32: 1427–1433, 1989.
- Conn DL, McDuffie FC, Kazmier FJ et al: Coagulation abnormalities in rheumatoid disease. Arthritis Rheum 19: 1237–1243, 1976.
- Inoh M, Tokuda M, Kiuchi H et al: Evaluating systemic lupus erythematosus disease activity using molecular markers of hemostasis. Arthritis Rheum 39: 287–291, 1996.
- Inamo Y, Pemberton S, Tuddenham EGD et al: Increase of activated factor Vila and haemostatic molecular markers in juvenile chronic arthritis. Br J Rheumatol 34: 466–469, 1995.
- Beckham JC, Caldwell DS, Peterson BL et al: Disease severity in rheumatoid arthritis: relationships of plasma tumor necrosis factor-a, soluble interleukin 2-receptor, soluble CD4/CD8 ratio, neopterin, and fibrin D-dimer to traditional severity and functional measures. J Clin Invest 12: 353–361, 1992.
- Arnett FC, Adworthy SM, Bloch DA et al: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31: 315–324, 1988.
- Steinbroker O, Traeger CH, Batterman RC: Therapeutic criteria in rheumatoid arthritis. J Am Med Ass 140: 659–662, 1949.
- Lansbury J: Methods for evaluating rheumatoid arthritis. In Arthritis and Allied Conditions, 7th edn (Hollander JL, McCarty DJ, Eds), pp. 269–291. Lea and Febiger, Philadelphia, 1966.
- Pelzer H, Schwarz A, Heimburger N: Determination of human thrombin-antithrombin III complex in plasma with an enzyme-linked immunosorbent assay. Thromb Haemostas 59: 101–106, 1988.
- Elms MJ, Bunce IH, Bundesen PG et al: Measurement of crosslinked fibrin degradation products — an immunoassay using monoclonal antibodies. Thromb Haemostas 50: 591–594, 1983.